Sinopharm Group Co. Ltd. (SHTDY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    11.74
    -0.08 (-0.68%)
    At close: Sep 04, 2025, 3:51 PM
    11.78
    0.34%
    After-hours: Sep 04, 2025, 03:51 PM EDT

    Sinopharm Balance Sheet Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 54.31B 63.81B 55.22B 43.53B
    Short-Term Investments
    		 158K 547K 498K 11.75M
    Long-Term Investments
    		 10.89B 10.55B 9.84B 9.17B
    Other Long-Term Assets
    		 3.5B 7.94B 3.73B 3.73B
    Receivables
    		 206.72B 189.79B 171.2B 172.58B
    Inventory
    		 62.35B 60.03B 60.93B 51.5B
    Other Current Assets
    		 14.05B 12.17B 28.86B 20.49B
    Total Current Assets
    		 347.45B 336.84B 319.41B 290.92B
    Property-Plant & Equipment
    		 17.61B 18.05B 17.79B 17.6B
    Goodwill & Intangibles
    		 10.97B 10.02B 12.03B 12.2B
    Total Long-Term Assets
    		 45.38B 46.56B 45.37B 44.49B
    Total Assets
    		 392.83B 383.39B 364.78B 335.41B
    Account Payables
    		 156.87B 146.63B 137.09B 128.43B
    Deferred Revenue
    		 n/a n/a 28B 21.62B
    Short-Term Debt
    		 62.73B 54.73B 53B 55.15B
    Other Current Liabilities
    		 16.57B 29.5B 33.67B 25.82B
    Total Current Liabilities
    		 250.38B 241.49B 234.96B 219.31B
    Long-Term Debt
    		 8.64B 13.83B 11.75B 8.42B
    Other Long-Term Liabilities
    		 2.82B 4.33B 4.79B 4.78B
    Total Long-Term Liabilities
    		 15.77B 21.59B 19.74B 16.45B
    Total Liabilities
    		 266.14B 263.08B 254.71B 235.76B
    Total Debt
    		 76.39B 73.78B 69.59B 68.37B
    Common Stock
    		 3.12B 3.12B 3.12B 3.12B
    Retained Earnings
    		 53.74B 51.2B 42.87B 38.52B
    Comprehensive Income
    		 n/a -4.37B -4.39B -4.39B
    Shareholders Equity
    		 78.88B 74.58B 68.07B 61.89B
    Total Investments
    		 10.89B 10.55B 9.84B 9.18B

    Add to Watchlist